MRNA logo

MRNA

Moderna Inc.

$24.47
-$0.36(-1.45%)
53
Overall
60
Value
50
Tech
50
Quality
Market Cap
$9.41B
Volume
9.77M
52W Range
$23.15 - $79.96
Target Price
$41.81
Order:

Income Statement

MetricTrendChart
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$135.1M$60.2M$803.0M$18.5B$19.3B$6.8B$3.2B
Total Revenue
$135.1M$60.2M$274.0M$17.7B$18.9B$6.8B$3.2B
COST OF GOODS SOLD
Cost of Revenue
----$8.0M$2.6B$5.4B$4.7B$1.5B
GROSS PROFIT
Gross Profit
$135.1M$60.2M$266.0M$15.1B$13.5B$2.2B$1.8B
OPERATING EXPENSES
Operating Expenses
$548.3M$605.9M$1.6B$2.6B$4.0B$6.4B$5.7B
Research & Development
$454.1M$496.3M$1.4B$2.0B$3.3B$4.8B$4.5B
Research Expense
$454.1M$496.3M$1.4B$2.0B$3.3B$4.8B$4.5B
Selling, General & Administrative
$94.3M$109.6M$188.0M$567.0M$1.1B$1.5B$1.2B
Selling & Marketing Expenses
--------$121.0M$204.0M$146.0M
General & Administrative Expenses
$94.3M$109.6M$188.0M$567.0M$1.1B$1.5B$1.2B
Depreciation & Amortization
$24.9M$31.0M$31.0M$232.0M$348.0M$617.0M$185.0M
Depreciation & Amortization
$24.9M$31.0M$31.0M--------
Amortization
--$309.0K$1.0M$189.0M$280.0M$552.0M$74.0M
OPERATING INCOME
Operating income
$-413.3M$-545.7M$-763.0M$13.3B$9.4B$-4.2B$-3.9B
EBITDA
$-359.5M$-477.2M$-703.1M$13.5B$9.9B$-3.3B$-3.4B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--$6.6M$9.9M$18.0M------
Intinc
$27.0M$38.5M$25.0M$18.0M$200.0M$421.0M$425.0M
Net Non-Operating Interest Income/Expense
$27.0M$38.5M$25.0M$18.0M$-171.0M$421.0M$425.0M
Other Income/Expense
$-1.8M$7.5M$6.0M$29.0M$-16.0M$124.0M$87.0M
Other Special Charges
$1.8M$-7.5M$-6.0M$-29.0M$-45.0M$-124.0M$-87.0M
SPECIAL ITEMS
Special Income Charges
----$-1.6M--------
Impairment of Capital Assets
----$1.6M--------
PRE-TAX INCOME
EBIT
$-384.4M$-508.2M$-734.1M$13.3B$9.6B$-3.9B$-3.6B
Pre-Tax Income
$-384.4M$-514.7M$-744.0M$13.3B$9.6B$-3.9B$-3.6B
INCOME TAX
Tax Provision
$326.0K$-695.0K$3.0M$1.1B$1.2B$772.0M$-46.0M
NET INCOME
Net Income
$-384.7M$-514.0M$-747.0M$12.2B$8.4B$-4.7B$-3.6B
Net Income (Continuing Operations)
$-384.7M$-514.0M$-747.0M$12.2B$8.4B$-4.7B$-3.6B
Net Income (Discontinued Operations)
$-384.7M$-514.0M$-747.0M$12.2B$8.4B$-4.7B$-3.6B
Net Income (Common Stockholders)
$-401.9M$-514.0M$-747.0M$12.2B$8.4B$-4.7B$-3.6B
Normalized Income
----------$-3.1B$-3.7B
TOTALS
Total Expenses
$548.3M$605.9M$1.6B$5.2B$9.5B$11.1B$7.2B
SHARE & EPS DATA
Average Shares Outstanding
$81.1M$330.8M$381.3M$403.0M$394.0M$382.0M$384.0M
Average Shares Outstanding (Diluted)
$81.1M$330.8M--$431.0M$416.0M$382.0M$384.0M
Shares Outstanding
$329.0M$368.6M$399.8M$402.9M$386.3M$382.1M$385.8M
Basic EPS
$-4.95$-1.55$-1.96$30.31$21.26$-12.33$-9.28
Basic EPS (Continuing Operations)
$-4.95$-1.55$-1.96$30.31$21.26$-12.33$-9.28
Diluted EPS
$-4.95$-1.55$-1.96$28.29$20.12$-12.33$-9.28
Diluted EPS (Continuing Operations)
------$28.29$20.12$-12.33$-9.28
OTHER METRICS
Accretion On Preferred Stock
$4.1M------------
Accrued Preferred Stock Dividends
$13.0M------------
Other Gand A
$94.3M$109.6M$188.0M$567.0M$1.1B$1.5B$1.2B
Otherunder Preferred Stock Dividend
$17.1M------------
Preferred Stock Dividends
$17.1M------------
Rent And Landing Fees
$19.1M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2MRNA$24.47-1.4%9.77M
3
4
5
6

Get Moderna Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.